Authors:
Porter, DL
Luger, SM
Duffy, KM
Stadtmauer, EA
Laport, G
Schuster, SJ
Orloff, G
Tsai, D
McDaid, K
Kathakali, A
Leonard, DGB
Antin, JH
Citation: Dl. Porter et al., Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation, BIOL BLOOD, 7(4), 2001, pp. 230-238
Authors:
Tsai, DE
Hardy, CL
Tomaszewski, JE
Kotloff, RM
Oltoff, KM
Somer, BG
Schuster, SJ
Porter, DL
Montone, KT
Stadtmauer, EA
Citation: De. Tsai et al., Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult patients, TRANSPLANT, 71(8), 2001, pp. 1076-1088
Authors:
Stadtmauer, EA
Tsai, DE
Sickles, CJ
Mick, R
Luger, SM
Porter, DL
Mangan, PA
Schuchter, LM
Schuster, SJ
Loh, EY
Magee, DA
Sachs, RA
Wall, ME
Moore, J
Buzby, GP
Zaleta, E
Kamoun, M
Silberstein, LE
Citation: Ea. Stadtmauer et al., Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination, MED ONCOL, 16(4), 1999, pp. 279-288
Authors:
Garcia-Manero, G
Schuster, SJ
Patrick, H
Martinez, J
Citation: G. Garcia-manero et al., Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases, AM J HEMAT, 60(2), 1999, pp. 130-135
Authors:
Hurford, MT
Gujral, S
Schuster, SJ
Schwarting, R
Citation: Mt. Hurford et al., Extramedullary myeloid cell tumor of the urinary bladder in a patient withmyelodysplastic syndrome, PATH RES PR, 195(10), 1999, pp. 699-703
Authors:
Tsai, DE
Moore, HCF
Hardy, CL
Porter, DL
Loh, EY
Vaughn, DJ
Luger, S
Schuster, SJ
Stadtmauer, EA
Citation: De. Tsai et al., Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation, BONE MAR TR, 24(5), 1999, pp. 521-526
Authors:
Means, RT
Allen, J
Sears, DA
Schuster, SJ
Citation: Rt. Means et al., Serum soluble transferrin receptor and the prediction of marrow aspirate iron results in a heterogeneous group of patients, CLIN LAB H, 21(3), 1999, pp. 161-167
Citation: G. Garcia-manero et Sj. Schuster, Should autologous or allogeneic stem-cell therapy be a part of consolidation therapy for all cases of adult acute myelogenous leukemia? - Response, SEMIN ONCOL, 26(1), 1999, pp. XVI-XVII